Cancer treatment systems maker
BSD Medical
(
BSDM
) said that its MicroThermX Microwave Ablation system has
successfully treated 100 patients at hospitals across the U.S.
Physicians have used the innovative therapy system to treat
patients with liver, kidney and lung cancers.
The Utah-based company also noted that these treatments have
delivered revenues from the sale of disposable SynchroWave antennas
(used with the MicroThermX system). These high-end antennas, used
during ablation treatment, are expected to generate a significant
revenue stream moving ahead.
The company also booked revenues from its fee-per-use equipment
rental program. BSD Medical's equipment rental program is aimed at
maximizing revenues from MicroThermX produ cts and boost market
penetration.
The MicroThermX system reached the U.S. market in December 2010.
Subsequently, it was introduced in Europe in January 2011. The
MicroThermX system is a transportable, cutting-edge proprietary
product, which includes a microwave generator, single-use antennas
and a temperature monitoring mechanism. It is capable of generating
significant levels of power with one generator. Its usage helps
approach larger and more uniform areas of ablation during a
procedure.
The MicroThermX system utilizes BSD Medical's proprietary
synchronous phased array technology to deliver precision-guided
microwave energy to ablate soft tissues using a single-patient-use
disposable antenna.
The minimally-invasive MicroThermX system has been developed to
provide treatments as a stand-alone therapy and has applications in
open surgical and percutaneous (via needle-puncture of the skin)
ablation procedures. The global market for soft tissue ablation has
been estimated to exceed $2.3 billion, offering a significant
opportunity for BSD Medical.
BSD Medical provides hyperthermia and ablation therapy systems
to treat cancer and benign diseases. It competes with established
players like
Boston Scientific
(
BSX
) and
Angiodynamics
(
ANGO
) in the thermal ablation market.
ANGIODYNAMICS (
ANGO
): Free Stock Analysis Report
BOSTON SCIENTIF (
BSX
): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment
Research